 Mizuho Securities analystMara Goldsteinmaintained aBuyrating on Corvus Pharmaceuticals CRVSResearch Report yesterday and set a price target of7.00. The companys shares closed last Thursday at 2.43.According toTipRanks.com, Goldstei 